Satsuma Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Satsuma Pharmaceuticals, Inc.‘s stocks are currently a part of 18 hedge funds’ portfolios, which represents 23.21% of the total amount of its stocks outstanding. This makes up a total of 7.43M shares of Satsuma Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -62.54% or -12.40M shares fewer. As for the holding position changes, 11.11% (2) of current hedge fund investors increased the number of shares held, 22.22% (4) of current holders sold a part of the shares held, and 16.67% (3) closed the holdings completely. 4 hedge funds are new holders of Satsuma Pharmaceuticals, Inc. stock in Q1 2023, it is 22.22% of total holders.
Hedge funds holding Satsuma Pharmaceuticals (Q1 2017 – Q1 2023)
| Q1 2017 | 0 |
|---|---|
| Q3 2019 | 30 |
| Q4 2019 | 32 |
| Q1 2020 | 36 |
| Q2 2020 | 50 |
| Q3 2020 | 46 |
| Q4 2020 | 48 |
| Q1 2021 | 61 |
| Q2 2021 | 57 |
| Q3 2021 | 45 |
| Q4 2021 | 32 |
| Q1 2022 | 33 |
| Q2 2022 | 30 |
| Q3 2022 | 40 |
| Q4 2022 | 34 |
| Q1 2023 | 18 |
Hedge funds changes in Satsuma Pharmaceuticals positions (Q1 2017 – Q1 2023)
| Q1 2017 | 0 | 0 | 0 | 1 | -1 |
|---|---|---|---|---|---|
| Q3 2019 | 30 | 0 | 0 | 0 | 0 |
| Q4 2019 | 17 | 7 | 3 | 10 | -5 |
| Q1 2020 | 6 | 14 | 9 | 2 | 5 |
| Q2 2020 | 18 | 21 | 6 | 4 | 1 |
| Q3 2020 | 15 | 10 | 15 | 19 | -13 |
| Q4 2020 | 12 | 13 | 15 | 9 | -1 |
| Q1 2021 | 16 | 22 | 14 | 3 | 6 |
| Q2 2021 | 12 | 15 | 22 | 16 | -8 |
| Q3 2021 | 5 | 14 | 17 | 17 | -8 |
| Q4 2021 | 2 | 9 | 11 | 13 | -3 |
| Q1 2022 | 4 | 9 | 11 | 3 | 6 |
| Q2 2022 | 3 | 8 | 8 | 5 | 6 |
| Q3 2022 | 15 | 9 | 10 | 5 | 1 |
| Q4 2022 | 10 | 8 | 11 | 17 | -12 |
| Q1 2023 | 4 | 2 | 4 | 3 | 5 |
Hedge funds changes in Satsuma Pharmaceuticals stock options (Q1 2017 – Q1 2023)
| Q1 2017 | 0 | 0 |
|---|---|---|
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 88,000 | 278,000 |
| Q3 2021 | 87,000 | 259,000 |
| Q4 2021 | 0 | 1,000 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 5,302,000 | 67,000 |
| Q4 2022 | 262,440 | 1,980 |
| Q1 2023 | 0 | 0 |